Science Explorer Back to mapMap
Discussion
Company · Aubonne · Switzerland

Merck Serono S.A. (Switzerland)

In research, Merck Serono S.A. (Switzerland) stands highest in Health Sciences (#6,623 of 16,688 worldwide), Medicine (#6,204 of 14,558 worldwide) and Life Sciences (#6,014 of 11,023 worldwide), over all time.

World rank, all time
#16,839
of 34,923
Rank in Switzerland
#195
of 378
Research works
458
▲ 6% vs 2018-21
Citations
20k
44.2 per fractional work
Top-10% rate
8.3%
all institutions 10.0%
vs its own fields
1.16×
1.00× is exactly expected
Open access
44%
world 40%
International
61%
world 18%

What is Merck Serono S.A. (Switzerland) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #6,623 of 16,688 14.2%209
MedicineField #6,204 of 14,558 14.0%201
Life SciencesDomain #6,014 of 11,023 14.1%170

Each strip is that field's whole ranked pool, with the notch where Merck Serono S.A. (Switzerland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Merck Serono S.A. (Switzerland) work in?

In 2022-now, 47% of research at Merck Serono S.A. (Switzerland) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (15%), Social Sciences (6%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 25 fractional works · 46.6% of its workMedicine: 24 fractional works · 44.5% of its workPathology and Forensic Medicine: 4 fractional works · 6.8% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 5.0% of its workOncology: 3 fractional works · 5.0% of its workRheumatology: 3 fractional works · 4.6% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 4.3% of its workPulmonary and Respiratory Medicine: 2 fractional works · 3.1% of its workGenetics: 1 fractional works · 2.2% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 2.2% of its workHematology: 1 fractional works · 2.1% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.9% of its workSurgery: 1 fractional works · 1.2% of its workNeurology: 1 fractional works · 1.2% of its workReproductive Medicine: 0 fractional works · 0.8% of its workHepatology: 0 fractional works · 0.8% of its workInfectious Diseases: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.6% of its workOtorhinolaryngology: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.5% of its workFamily Practice: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.7% of its workHealth Professions: 1 fractional works · 1.6% of its workGeneral Health Professions: 0 fractional works · 0.9% of its workSpeech and Hearing: 0 fractional works · 0.4% of its workEmergency Medical Services: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.1% of its workLife Sciences: 13 fractional works · 23.6% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 15.2% of its workMolecular Biology: 7 fractional works · 12.0% of its workCell Biology: 0 fractional works · 0.7% of its workCancer Research: 0 fractional works · 0.6% of its workBiophysics: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.5% of its workBiotechnology: 0 fractional works · 0.4% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 4.3% of its workImmunology: 2 fractional works · 3.5% of its workParasitology: 0 fractional works · 0.9% of its workAgricultural and Biological Sciences: 2 fractional works · 2.8% of its workPlant Science: 1 fractional works · 1.1% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 0.9% of its workForestry: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.4% of its workSocial Sciences: 8 fractional works · 15.0% of its workSocial Sciences: 3 fractional works · 5.6% of its workLaw: 2 fractional works · 3.1% of its workLife-span and Life-course Studies: 0 fractional works · 0.6% of its workPolitical Science and International Relations: 0 fractional works · 0.6% of its workEducation: 0 fractional works · 0.5% of its workSociology and Political Science: 0 fractional works · 0.4% of its workHealth: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 3 fractional works · 4.8% of its workEconomics and Econometrics: 3 fractional works · 4.6% of its workFinance: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 1 fractional works · 2.4% of its workMarketing: 1 fractional works · 1.1% of its workAccounting: 0 fractional works · 0.6% of its workStrategy and Management: 0 fractional works · 0.4% of its workManagement of Technology and Innovation: 0 fractional works · 0.3% of its workDecision Sciences: 1 fractional works · 1.5% of its workInformation Systems and Management: 1 fractional works · 1.2% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.3% of its workPsychology: 0 fractional works · 0.4% of its workSocial Psychology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.3% of its workPhysical Sciences: 8 fractional works · 14.7% of its workEngineering: 2 fractional works · 4.4% of its workBiomedical Engineering: 1 fractional works · 2.3% of its workSafety, Risk, Reliability and Quality: 1 fractional works · 1.1% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.7% of its workElectrical and Electronic Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 1 fractional works · 2.6% of its workArtificial Intelligence: 1 fractional works · 1.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.6% of its workComputer Science Applications: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 2.6% of its workElectronic, Optical and Magnetic Materials: 1 fractional works · 1.8% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workPolymers and Plastics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 1 fractional works · 1.7% of its workEcology: 0 fractional works · 0.9% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workChemistry: 1 fractional works · 1.1% of its workSpectroscopy: 0 fractional works · 0.5% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.9% of its workAstronomy and Astrophysics: 0 fractional works · 0.9% of its workEnergy: 0 fractional works · 0.6% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.6% of its workMathematics: 0 fractional works · 0.6% of its workStatistics and Probability: 0 fractional works · 0.6% of its workChemical Engineering: 0 fractional works · 0.2% of its workBioengineering: 0 fractional works · 0.2% of its workALL ITS WORKMerck Serono S.A.(Switzerland)54fractional works, 2022-now
Life Sciences24%Physical Sciences15%Health Sciences47%Social Sciences15%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 24 fields, with their numbers
    1. Medicine2444.5%
    2. Health Professions11.6%
    3. Veterinary00.4%
    4. Nursing00.1%
    1. Biochemistry, Genetics and Molecular Biology815.2%
    2. Immunology and Microbiology24.3%
    3. Agricultural and Biological Sciences22.8%
    4. Pharmacology, Toxicology and Pharmaceutics00.9%
    5. Neuroscience00.4%
    1. Social Sciences35.6%
    2. Economics, Econometrics and Finance34.8%
    3. Business, Management and Accounting12.4%
    4. Decision Sciences11.5%
    5. Psychology00.4%
    6. Arts and Humanities00.3%
    1. Engineering24.4%
    2. Computer Science12.6%
    3. Materials Science12.6%
    4. Environmental Science11.7%
    5. Chemistry11.1%
    6. Physics and Astronomy00.9%
    7. Energy00.6%
    8. Mathematics00.6%
    9. Chemical Engineering00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.60× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.84× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 4.30× its world share, 2 worksImmunology and Micro…Neuroscience: 0.25× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.49× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.58× its world share, 0 worksChemical EngineeringChemistry: 0.68× its world share, 1 worksChemistryComputer Science: 0.34× its world share, 1 worksComputer ScienceEnergy: 0.67× its world share, 0 worksEnergyEngineering: 0.30× its world share, 2 worksEngineeringEnvironmental Science: 0.34× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.73× its world share, 1 worksMaterials ScienceMathematics: 0.51× its world share, 0 worksMathematicsPhysics and Astronomy: 0.41× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.60× its world share, 1 worksHealth ProfessionsMedicine: 2.32× its world share, 24 worksMedicineNursing: 0.21× its world share, 0 worksNursingVeterinary: 3.00× its world share, 0 worksVeterinaryArts and Humanities: 0.10× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.74× its world share, 1 worksBusiness, Management…Decision Sciences: 1.54× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 2.27× its world share, 3 worksEconomics, Econometr…Psychology: 0.14× its world share, 0 worksPsychologySocial Sciences: 0.44× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.3×. Every wedge is a field page.

All 24 fields, with their numbers
  1. Immunology and Microbiology4.30×2 works
  2. Veterinary3.00×0 works
  3. Biochemistry, Genetics and Molecular Biology2.84×8 works
  4. Pharmacology, Toxicology and Pharmaceutics2.49×0 works
  5. Medicine2.32×24 works
  6. Economics, Econometrics and Finance2.27×3 works
  7. Decision Sciences1.54×1 works
  8. Business, Management and Accounting0.74×1 works
  9. Materials Science0.73×1 works
  10. Chemistry0.68×1 works
  11. Energy0.67×0 works
  12. Agricultural and Biological Sciences0.60×2 works
  13. Health Professions0.60×1 works
  14. Chemical Engineering0.58×0 works
  15. Mathematics0.51×0 works
  16. Social Sciences0.44×3 works
  17. Physics and Astronomy0.41×0 works
  18. Computer Science0.34×1 works
  19. Environmental Science0.34×1 works
  20. Engineering0.30×2 works
  21. Neuroscience0.25×0 works
  22. Nursing0.21×0 works
  23. Psychology0.14×0 works
  24. Arts and Humanities0.10×0 works

Who are the top researchers at Merck Serono S.A. (Switzerland)?

Ranked on the quality score, Christian Rommel, Amanda E. I. Proudfoot and Rob Hooft van Huijsduijnen lead among researchers whose main affiliation is Merck Serono S.A. (Switzerland).

  1. 1 Christian Rommel Switzerland · #86,780 worldwide 14k citations · 165 works
  2. 2 Amanda E. I. Proudfoot Switzerland · #119,209 worldwide 26k citations · 270 works
  3. 3 Rob Hooft van Huijsduijnen Switzerland · #172,997 worldwide 9.2k citations · 99 works
  4. 4 Bruno E. Antonsson Switzerland · #256,531 worldwide 16k citations · 118 works
  5. 5 Montserrat Camps Switzerland · #353,845 worldwide 9.8k citations · 83 works
  6. 6 Thomas Rückle Switzerland · #464,431 worldwide 4.9k citations · 68 works
  7. 7 Christian Chabert Switzerland · #484,900 worldwide 4.2k citations · 29 works
  8. 8 Jérôme Wojcik Switzerland · #552,853 worldwide 6.8k citations · 91 works
  9. 9 Jeffrey P. Shaw Switzerland · #603,505 worldwide 3.2k citations · 36 works
  10. 10 Colin M. Howles Switzerland · #792,693 worldwide 5.2k citations · 121 works
All ranked researchers at Merck Serono S.A. (Switzerland)

What are the most cited papers from Merck Serono S.A. (Switzerland)?

The most cited paper from Merck Serono S.A. (Switzerland) is "2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative" (Daniel Aletaha et al., 2010), with 9,731 citations. Next come "Unfolding the role of protein misfolding in neurodegenerative diseases" (1,533) and "RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation" (1,204).

Most cited papers
#PaperReleasedCitations
1 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative Daniel Aletaha et al. · Arthritis & Rheumatism Open access 10 Aug 2010 9,731
2 Unfolding the role of protein misfolding in neurodegenerative diseases Claudio A. Soto · Nature reviews. Neuroscience Review 2003 1,533
3 RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation Laura Codarri Deak, Gábor Gyülvészi, Vinko Toševski et al. · Nature Immunology 24 Apr 2011 1,204
4 A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis Gavin Giovannoni, Gıancarlo Comı, Stuart D. Cook et al. · New England Journal of Medicine Open access 20 Jan 2010 1,032
5 Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain Iain P. Chessell, Jonathan P. Hatcher, C. Bountra et al. · Pain 8 Feb 2005 795
All 60 most cited papers, with filters and sorting

Which keywords describe research at Merck Serono S.A. (Switzerland)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Cognitive Impairment, Autoantibodies, Prognostic Factors, Biopharmaceuticals and Diagnostic Criteria.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation5▲ 83×3 topics
  2. Monoclonal Antibodies5▲ 98×3 topics
  3. Therapeutic Antibodies4▲ 113×2 topics
  4. Autoantibodies3▲ 22×5 topics
  5. Cognitive Impairment3▲ 21×3 topics
  6. Cancer3▲ 3.9×14 topics
  7. Prognostic Factors3▲ 12×8 topics
  8. Biopharmaceuticals3▲ 95×3 topics
  9. Diagnostic Criteria3▲ 20×2 topics
  10. Cell Culture2▲ 39×2 topics
  11. Immunogenicity2▲ 109×2 topics
  12. Inflammation2▲ 2.1×13 topics
  13. Multiple Sclerosis2▲ 120×1 topic
  14. Neuromyelitis Optica2▲ 120×1 topic
  15. Chemotherapy2▲ 6.0×13 topics
  16. Antibody Engineering2▲ 75×1 topic
  17. Fc Receptors2▲ 75×1 topic
  18. Recombinant Proteins2▲ 127×2 topics
  19. Chromatography2▲ 253×1 topic
  20. Monoclonal Antibody2▲ 71×2 topics
  21. Protein Aggregation2▲ 74×3 topics
  22. Stability2▲ 17×1 topic
  23. Mammalian Cells2▲ 160×1 topic
  24. Recombinant Protein2▲ 160×1 topic
  25. Clinical Trials2▲ 5.0×7 topics
  26. Immunotherapy2▲ 4.5×10 topics
  27. Human Rights2▲ 3.0×5 topics
  28. Toll-like Receptors2▲ 28×2 topics
  29. Treatment2▲ 2.5×8 topics
  30. Innovation2▲ 2.6×8 topics
  31. Rituximab2▲ 19×3 topics
  32. Targeted Therapy2▲ 12×5 topics
  33. Antiphospholipid Syndrome1▲ 52×1 topic
  34. Minimal Residual Disease1▲ 36×2 topics
  35. Systemic Lupus Erythematosus1▲ 46×1 topic
  36. Therapeutic Targets1▲ 15×3 topics
  37. Chronic Lymphocytic Leukemia1▲ 46×1 topic
  38. Genomic Aberrations1▲ 46×1 topic
  39. Liquid Crystals1▲ 119×1 topic
  40. Self-Organization1▲ 57×1 topic

Which research topics does Merck Serono S.A. (Switzerland) publish most on?

By volume in 2022-now: Multiple Sclerosis Research Studies, Monoclonal and Polyclonal Antibodies Research, Protein purification and stability and Viral Infectious Diseases and Gene Expression in Insects.

  1. 1 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 Protein purification and stability Molecular Biology 2 works
  4. 4 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
  5. 5 Systemic Lupus Erythematosus Research Rheumatology 1 works
  6. 6 Chronic Lymphocytic Leukemia Research Genetics 1 works
  7. 7 Liquid Crystal Research Advancements Electronic, Optical and Magnetic Materials 1 works
  8. 8 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  9. 9 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
  10. 10 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.2%not open55.8%

World: 40% of research is openly available.

with international co-authors61.2%domestic only38.8%

World: 18% is written across borders.

How has Merck Serono S.A. (Switzerland)'s research output changed?

Output in 2022-2025 was 6% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Merck Serono S.A. (Switzerland) as a percentage of every work published that year, 0.00018% in 2024.

still counting0.00050%0.0010%0.0015%Merck Serono S.A. (Switzerland)0.00018% in 202519801990200020102020

Fractional works of Merck Serono S.A. (Switzerland) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

10%20%30%Merck Serono S.A. (Switzerland)12.6% in 2013all institutions10.0% in 20132010

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 25.1% in 2008.

Other research institutions in Aubonne

All research institutions in Aubonne

Share Merck Serono S.A. (Switzerland)'s ranking

Merck Serono S.A. (Switzerland) on Science Explorer

A card with Merck Serono S.A. (Switzerland)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Merck Serono S.A. (Switzerland). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.